...
首页> 外文期刊>International journal of biological sciences >Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation
【24h】

Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation

机译:瞬时受体电位锚蛋白1通道参与动脉粥样硬化和巨噬细胞-泡沫细胞形成

获取原文

摘要

Transient receptor potential ankyrin 1 channel (TRPA1) plays an important role in the pathogenesis of inflammatory diseases, yet its role and the underlying mechanism in atherosclerosis remain unclear. We aimed to investigate the role of TRPA1 in atherosclerosis and foam-cell formation in vivo in mice and in vitro in mouse macrophages. Histopathology was examined by hematoxylin and eosin staining, levels of cytokines and lipid profile were evaluated by assay kits, and protein expression was determined by western blot analysis. TRPA1 expression was increased in macrophage foam cells in atherosclerotic aortas of apolipoprotein E-deficient (apoE-/-) mice. Atherosclerotic lesions, hyperlipidemia and systemic inflammation were worsened with chronic administration of the TRPA1 channel antagonist HC030031 or genetic ablation of TRPA1 (TRPA1-/-) in apoE-/- mice. Treatment with allyl isothiocyanate (AITC, a TRPA1 agonist) retarded the progression of atherosclerosis in apoE-/- mice but not apoE-/-TRPA1-/- mice. Mouse macrophages showed oxidized low-density lipoprotein (oxLDL) activated TRPA1 channels. OxLDL-induced lipid accumulation of macrophages was exacerbated by HC030031 or loss of function of TRPA1. Inhibition of TRPA1 activity did not alter oxLDL internalization but impaired cholesterol efflux by downregulating the ATP-binding cassette transporters. Furthermore, tumor necrosis factor-α-induced inflammatory response was attenuated in AITC-activated macrophages. TRPA1 may be a pivotal regulator in the pathogenesis of atherosclerosis and cholesterol metabolism of macrophage foam cells.
机译:瞬态受体电位锚蛋白1通道(TRPA1)在炎症性疾病的发病机理中起着重要作用,但其作用及其在动脉粥样硬化中的潜在机制尚不清楚。我们旨在调查TRPA1在小鼠体内和小鼠巨噬细胞中在动脉粥样硬化和泡沫细胞形成中的作用。通过苏木精和曙红染色检查组织病理学,通过检测试剂盒评估细胞因子水平和脂质分布,并通过蛋白质印迹分析确定蛋白质表达。载脂蛋白E缺陷(apoE -/-)小鼠的动脉粥样硬化主动脉中巨噬细胞泡沫细胞中TRPA1表达增加。长期给予apoE -//-小鼠TRPA1通道拮抗剂HC030031或TRPA1基因消融(TRPA1 -/-)会使动脉粥样硬化病变,高脂血症和全身性炎症恶化。用异硫氰酸烯丙酯(AITC,TRPA1激动剂)处理可抑制apoE -/-小鼠的动脉粥样硬化进展,但不能抑制apoE -/- TRPA1 -/-< / sup>小鼠。小鼠巨噬细胞显示了氧化的低密度脂蛋白(oxLDL)激活的TRPA1通道。 HC030031或TRPA1功能丧失会加剧OxLDL诱导的巨噬细胞脂质蓄积。抑制TRPA1活性不会改变oxLDL内在化,但会通过下调ATP结合盒转运蛋白而损害胆固醇外排。此外,在AITC激活的巨噬细胞中,肿瘤坏死因子-α诱导的炎症反应减弱。 TRPA1可能是巨噬细胞泡沫细胞的动脉粥样硬化和胆固醇代谢的关键机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号